Eagle Veterinary Technology Co.Ltd (044960) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.027x

Based on the latest financial reports, Eagle Veterinary Technology Co.Ltd (044960) has a cash flow conversion efficiency ratio of 0.027x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.50 Billion ≈ $1.01 Million USD) by net assets (₩54.68 Billion ≈ $37.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 044960 company net worth for the company's overall valuation and market capitalisation.

Eagle Veterinary Technology Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Eagle Veterinary Technology Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Eagle Veterinary Technology Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eagle Veterinary Technology Co.Ltd ranked by their cash flow conversion efficiency. Explore Eagle Veterinary Technology Co.Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
L&P Global Berhad
KLSE:0268
0.032x
Sanatana Resources
V:STA
-0.300x
CPI Aerostructures Inc
NYSE:CVU
0.008x
Eildon Capital Group
AU:EDC
0.319x
United Homes Group Inc.
NASDAQ:UHG
0.021x
IL&FS Investment Managers Limited
NSE:IVC
-0.037x
Kwang Myung El
KO:017040
0.147x
Embrace Change Acquisition Corp Ordinary Shares
NASDAQ:EMCG
0.015x

Annual Cash Flow Conversion Efficiency for Eagle Veterinary Technology Co.Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Eagle Veterinary Technology Co.Ltd from 2014 to 2025. View 044960 stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩51.91 Billion
≈ $35.18 Million
₩5.51 Billion
≈ $3.73 Million
0.106x +18.84%
2024-12-31 ₩48.59 Billion
≈ $32.93 Million
₩4.34 Billion
≈ $2.94 Million
0.089x -17.31%
2023-12-31 ₩45.34 Billion
≈ $30.73 Million
₩4.89 Billion
≈ $3.32 Million
0.108x +1558.42%
2022-12-31 ₩42.95 Billion
≈ $29.11 Million
₩-317.89 Million
≈ $-215.43K
-0.007x -104.93%
2021-12-31 ₩40.83 Billion
≈ $27.67 Million
₩6.13 Billion
≈ $4.16 Million
0.150x -3.89%
2020-12-31 ₩37.74 Billion
≈ $25.57 Million
₩5.90 Billion
≈ $4.00 Million
0.156x +89.99%
2019-12-31 ₩35.53 Billion
≈ $24.08 Million
₩2.92 Billion
≈ $1.98 Million
0.082x +40.64%
2018-12-31 ₩34.55 Billion
≈ $23.41 Million
₩2.02 Billion
≈ $1.37 Million
0.058x +264.89%
2017-12-31 ₩31.91 Billion
≈ $21.63 Million
₩511.60 Million
≈ $346.70K
0.016x -83.77%
2016-12-31 ₩31.66 Billion
≈ $21.45 Million
₩3.13 Billion
≈ $2.12 Million
0.099x +420.08%
2015-12-31 ₩30.93 Billion
≈ $20.96 Million
₩-954.72 Million
≈ $-647.00K
-0.031x -148.03%
2014-12-31 ₩29.11 Billion
≈ $19.73 Million
₩1.87 Billion
≈ $1.27 Million
0.064x --

About Eagle Veterinary Technology Co.Ltd

KQ:044960 Korea Pharmaceuticals
Market Cap
$26.69 Million
₩39.38 Billion KRW
Market Cap Rank
#24240 Global
#1716 in Korea
Share Price
₩3115.00
Change (1 day)
-0.80%
52-Week Range
₩2765.00 - ₩4500.00
All Time High
₩11948.48
About

Eagle Veterinary Technology Co.,Ltd manufactures and sells animal health care products in South Korea. The company offers antibiotics, antibacterials, anthelmintics, antihistamins, and in the form of injectable, feed additives, oral liquids, and soluble powders for swine, poultry, and bovine. Eagle Veterinary Technology Co.,Ltd also exports its products to New Zealand, Australia, Vietnam, Kenya, … Read more